Enomoto K - Search Results

1

Phase II study of KRN8602, 3'-deamino-3'-morpholino-13-deoxo-10-hydroxycarminomycin hydrochloride, MX2 x HCl in patients with metastatic breast cancer.

Katsumata N, Watanabe T, Tominaga T, Ogawa M, Adachi I, Enomoto K, Kajiwara T, Kusama M, Yamada Y, Abe O. Katsumata N, et al. Among authors: enomoto k. Cancer Chemother Pharmacol. 1999;43(6):441-4. doi: 10.1007/s002800050921. Cancer Chemother Pharmacol. 1999. PMID: 10321502 Clinical Trial.

2

MX2; 3'-deamino-3'-morpholino-13-deoxy-10-hydroxycarminomycin (KRN8602) in refractory metastatic breast cancer: results of a preliminary phase II trial.

Watanabe T, Narabayashi M, Haga S, Yamada Y, Kawamura E, Enomoto K, Kusama M, Kimura K, Adachi I, Abe O. Watanabe T, et al. Among authors: enomoto k. Jpn J Clin Oncol. 1993 Aug;23(4):246-9. Jpn J Clin Oncol. 1993. PMID: 8411738 Clinical Trial.

3

[Phase I study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group].

Nomura Y, Abe O, Enomoto K, Fujiwara K, Tominaga T, Hayashi K, Uchino J, Takahashi M, Hayasaka A, Asaishi K, Okazaki M, Abe R, Kimishima I, Kajiwara T, Haga S, Shimizu T, Miyazaki I, Noguchi M, Yoshida M, Miura S, Taguchi T, Oota J, Sakai K, Kinoshita H, Tashiro H, et al. Nomura Y, et al. Among authors: enomoto k. Gan To Kagaku Ryoho. 1998 Mar;25(4):553-61. Gan To Kagaku Ryoho. 1998. PMID: 9530362 Clinical Trial. Japanese.

4

A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.

Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M. Ikeda T, et al. Among authors: enomoto k. Jpn J Clin Oncol. 1999 Jan;29(1):23-7. doi: 10.1093/jjco/29.1.23. Jpn J Clin Oncol. 1999. PMID: 10073147 Clinical Trial.

5

A randomized controlled comparative study of oral medroxyprogesterone acetate 1,200 and 600 mg in patients with advanced or recurrent breast cancer.

Koyama H, Tominaga T, Asaishi K, Abe R, Iino Y, Enomoto K, Miura S, Nomura Y, Nakazato H, Abe O. Koyama H, et al. Among authors: enomoto k. Oncology. 1999;56(4):283-90. doi: 10.1159/000011979. Oncology. 1999. PMID: 10343191 Clinical Trial.

6

Comparison of chemotherapy with or without medroxyprogesterone acetate for advanced or recurrent breast cancer.

Tominaga T, Abe O, Ohshima A, Hayasaka H, Uchino J, Abe R, Enomoto K, Izuo M, Watanabe H, Takatani O, et al. Tominaga T, et al. Among authors: enomoto k. Eur J Cancer. 1994;30A(7):959-64. doi: 10.1016/0959-8049(94)90123-6. Eur J Cancer. 1994. PMID: 7946592 Clinical Trial.

7

[Phase II study of CGS16949A, a new aromatase inhibitor--a dose finding study].

Tominaga T, Abe O, Asaishi K, Abe R, Enomoto K, Kajiwara T, Yoshida M, Wada T, Nomura Y. Tominaga T, et al. Among authors: enomoto k. Gan To Kagaku Ryoho. 1994 Mar;21(4):465-75. Gan To Kagaku Ryoho. 1994. PMID: 8129387 Clinical Trial. Japanese.

8

[Clinical evaluation of CGS16949A in advanced or recurrent breast cancer--a multi-institutional late phase II clinical trial].

Aoyama H, Asaishi K, Abe R, Kajiwara T, Enomoto K, Yoshida M, Ohasi Y, Tominaga T, Abe O. Aoyama H, et al. Among authors: enomoto k. Gan To Kagaku Ryoho. 1994 Mar;21(4):477-84. Gan To Kagaku Ryoho. 1994. PMID: 8129388 Clinical Trial. Japanese.

9

A phase II multi-institutional study of estra-1,3,5(10)-triene-3,17 beta-diol, 3-benzoate, 17[[4-[4-[bis(2-chloroethyl)amino]phenyl]-1- oxobutoxy]acetate] (KM2210), a novel antitumor agent, for advanced and recurrent breast carcinoma.

Kubota T, Abe O, Izuo M, Watanabe H, Enomoto K, Ohsawa N, Kuno K. Kubota T, et al. Among authors: enomoto k. Anticancer Res. 1993 Nov-Dec;13(6B):2361-5. Anticancer Res. 1993. PMID: 8135468 Clinical Trial.

10

[Phase I study of CGS16949A--a new aromatase inhibitor. Cooperative Study Group for CGS16949A].

Nomura Y, Abe O, Tominaga T, Tashiro H, Hisamatsu K, Enomoto K, Fujiwara K, Imoto S, Ando J, Hayashi K, et al. Nomura Y, et al. Among authors: enomoto k. Gan To Kagaku Ryoho. 1994 Feb;21(2):189-97. Gan To Kagaku Ryoho. 1994. PMID: 8311489 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

853 results

Search Page

Filters